Nutrigenomics Testing Market: By Product Type (Reagents and Kits, Services), Application (Obesity, Diabetes, Cancer, Cardiovascular Diseases, Others), Distribution Channel (Hospitals and Clinics, Online Platform, Others), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Nutrigenomics Testing Market was valued at USD 489.1 million in 2022 and is projected to grow at a 13.9% CAGR over 2023 to 2029. The study of how diet and nutrition impact the expression of a person's genetic composition and dietary factors that protect the genome from harm is known as nutrigenomics. Nutrigenomic testing, on the other hand, properly detects everyone’s genetic protein variants involved in enzyme conversion, nutrient delivery, and signalling pathways in the cell to discover metabolic deficiencies. The reagents and kits segment anticipated to grow at significant CAGR over the forecast years owing to increasing in R&D expenditure by biotechnology companies, expanding applications of molecular biology, technological advancements in the field of biotechnology, and growing demand for synthetic biology are key driving factors for reagents and kits segment. Moreover, market players are focusing on the launching new product and acquisition to maintain the growth in the forecasting market For instance In April 2019, Nutrigenomix, a global leader in genetic testing for personalized nutrition launched genetic test for vegetarian and vegan population that gives the opportunity to consumers to opt for plant-based personalized nutrition. Increasing burden of lifestyle disorders and gaining popularity of personalised diet. Some of the lifestyle diseases include heart disease, and stroke, obesity and diabetes welfare are a few factors driving the industry's growth over the forecasting period.

Nutrigenomics Testing Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Nutrigenomics Testing Market Dynamics

The rising incidence of obesity throughout the world will benefit the expansion of the nutrigenomics testing sector during the forecasting period. Genetic changes related with lipid and carbohydrate metabolic issues are one of the most common causes of obesity. Nutrigenomics testing allows for the discovery of molecular interactions between nutrition and the genome. This aids scientists in the creation and development of functional foods for the management of the body's weight control system and metabolism. As a result, the growing number of overweight people would increase demand for nutrigenetics testing, accelerating market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Nutrigenomics Testing Market Segmentation

By Product Type
  • Reagents and Kits
  • Services
By Application
  • Obesity
  • Diabetes
  • Cancer
  • Cardiovascular Diseases
  • Others
By Distribution Channel
  • Hospitals and Clinics
  • Online Platform
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Holistic Heal
  • GeneLink
  • Cura Integrative Medicine
  • Nutrigenomix
  • GX Sciences
  • Interleukin Genetics
  • NutraGene
  • Metagenics
  • Pathway Genomics
  • Salugen
  • Genelex
  • Gene Box
  • Xcode Life and Sanger Genomics.